Ebola ’emergency’ vaccines provide ethical blueprint for COVID-19 response
Despite not having safety and efficacy data from the final phase of clinical trials, China and Russia have already started COVID-19 vaccinations and have been widely criticized for prematurely exposing the public to these unlicensed vaccines. While this approach remains tenuous, it is not unprecedented for countries to issue emergency use authorizations for unlicensed vaccines during public health emergencies. In […]
Continue reading »